OPKO Health

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Earnings data Q1 2023

Earnings data Q2 2023

OPKO Health's (OPK) entry into a worldwide license and collaboration agreement with Merck is expected to aid in developing a vaccine against EBV.

OPKO Health (OPK) to Develop EBV Vaccine With Latest Tie-Up

Drugmaker Merck is supplying OPKO with cash to continue working on an Epstein-Barr vaccine. Although other vaccines aimed at the disease are in various degrees of development, OPKO's ModeX Therapeutics' MDX-2201 could be one of the first vaccines to be approved for this purpose.

Why OPKO Health Shares Jumped on Wednesday

Ardelyx

iBio

Rigel Pharmaceuticals

4 biotech penny stocks to watch right now. The post 4 Top Penny Stocks To Watch With Big Biotech News This Quarter appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Top Penny Stocks To Watch With Big Biotech News This Quarter

Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in Pharmaceuticals segment, its overall fourth-quarter results reflect soft performances.

OPKO Health (OPK) Q4 Earnings Match Estimates, Revenues Top

OPKO Health, Inc. (NASDAQ:OPK ) Q4 2022 Earnings Conference Call February 23, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Phillip Frost - Chairman & CEO Elias Zerhouni - President & Vice Chairman Steven Rubin - EVP, Administration & Director Gary Nabel - Chief Innovation Officer & Director Adam Logal - SVP, CFO, CAO & Treasurer Conference Call Participants Kevin Strang - Jefferies Jeffrey Cohen - Ladenburg Thalmann Edward Tenthoff - Piper Sandler Yale Jen - Laidlaw & Company Yi Chen - H.C. Wainwright & Co. Operator Good day, and welcome to the OPKO Health Fourth Quarter 2022 Financial Results Conference Call.

OPKO Health, Inc. (OPK) Q4 2022 Earnings Call Transcript

Conference call begins at 4:30 p.m. Eastern time today Conference call begins at 4:30 p.m. Eastern time today

OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results

Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in RAYALDEE.

Here's Why You Should Retain OPKO Health (OPK) Stock for Now

MIAMI, Feb. 16, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2022 after the close of the U.S. financial markets on Thursday, February 23, 2023. OPKO's senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on February 23rd beginning at 4:30 p.m. Eastern time.

OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023

CINtec ®  PLUS Cytology offered as a reflex test when cytology is NILM and HPV positive ELMWOOD PARK, N.J. , Feb. 9, 2023 /PRNewswire/ -- BioReference® Health LLC, one of the largest full-service specialty laboratories in the United States, announced today it will be one of the first commercial laboratories to use offer the CINtec® PLUS Cytology test from Roche Diagnostics.

BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings

MIAMI, Jan. 03, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 41st Annual J.P. Morgan Healthcare Conference being held January 9-12, 2023 at the Westin St. Francis in San Francisco. Management will be hosting one-on-one meetings with investors and will be presenting on Wednesday, January 11th at 4:30 p.m. Pacific time.

OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference

3 Reasons to Retain OPKO Health (OPK) Stock in Your Portfolio

OPKO Health (OPK) is likely to gain from the potential in RAYALDEE that targets a growing market coupled with new collaborations and acquisitions.

Here's Why You Should Hold OPKO Health (OPK) Stock For Now

OPKO Health's (OPK) third-quarter results reflect dismal segmental performances.

OPKO Health (OPK) Q3 Earnings Lag Estimates, Revenues Top

OPKO Health, Inc. (NASDAQ:OPK ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Phillip Frost - Chairman and Chief Executive Officer Adam Logal - SVP and Chief Financial Officer Jon Cohen - SVP and Executive Chairman Elias Zerhouni - President and Vice Chairman Conference Call Participants Kevin Strang - Jefferies Jeffrey S. Cohen - Ladenburg Thalmann Company Inc. Edward Tenthoff - Piper Sandler Operator Good day and welcome to the OPKO Health Third Quarter 2022 Financial Results Conference Call.

OPKO Health, Inc. (OPK) Q3 2022 Earnings Call Transcript

OPKO Health (OPK) delivered earnings and revenue surprises of -10% and 4.07%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

OPKO Health (OPK) Reports Q3 Loss, Tops Revenue Estimates

OPKO Health Reports Third Quarter 2022 Business Highlights and Financial Results

Medalist Diversified REIT Inc

Great Elm Group

US crude oil futures traded higher on Friday. Investors, meanwhile, focused on some notable insider trades.

OPKO Health And 2 Other Penny Stocks Are Aggressively Buying - Medalist Diversified REIT (NASDAQ:MDRR), Great Elm Group (NASDAQ:GEG)

Here's Why You Should Hold on to OPKO Health (OPK) Stock Now

OPKO Health, Inc. revenues and earnings numbers in Q2 both missed estimates. OPKO Health shares continue to fall but the CEO continues to buy.

OPKO Health: Assessing If Significant Potential Can Be Realized

Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in Rayaldee.

3 Reasons to Hold OPKO Health (OPK) Stock in Your Portfolio

MIAMI, Aug. 16, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK), a multinational biopharmaceutical and diagnostics company, today announced that Jon R. Cohen, M.D., is retiring from his role as Executive Chairman and Chief Executive Officer of BioReference Laboratories and Senior Vice President and a Director of OPKO. He will remain as an employed advisor to the company through the end of December 2022 and continue as a consultant for the following nine months to assist in positioning the company for accelerated growth. Effective immediately, Craig Allen, President and Chief Operating Officer, has been appointed Interim Chief Executive Officer, reporting to Elias Zerhouni, M.D., President of OPKO Health.

OPKO Health Announces Leadership Changes for BioReference Laboratories

Investors shrugged off the company's notably worse-than-expected quarterly results.

Why Opko Health Stock Was a Surprise Winner This Week

OPKO Health's (OPK) second-quarter results benefit from continued strength in its Pharmaceuticals segment.

OPKO Health (OPK) Stock Gains 2.1% Despite Q2 Earnings Miss

OPKO Health (OPK) delivered earnings and revenue surprises of -100% and 3.02%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

OPKO Health (OPK) Reports Q2 Loss, Lags Revenue Estimates

OPKO Health, Inc. (NASDAQ:OPK ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Phillip Frost - Chairman and Chief Executive Officer Adam Logal - SVP and Chief Financial Officer Jon Cohen - SVP and Executive Chairman Elias Zerhouni - President and Vice Chairman Conference Call Participants Kevin Strang - Jefferies Operator Good day and welcome to the OPKO Health's Second Quarter 2022 Financial Results Conference Call. All participants will be in a listen-only mode.

News for OPKO Health Stock (OPK)